Delivery Order SPE2DB22D9316-SPE2DB24FYN03
- Not listed
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at twenty-four thousand eight hundred thirty-one dollars by the Defense Logistics Agency under an existing indefinite delivery contract. The delivery order is for the supply of fourteen milliliter vials of Perjeta 420 mg to Defense Logistics Agency Troop Support Medical facilities. As a woman-owned small business, DMS Pharmaceutical Group holds this pharmaceutical prime vendor contract through December 2025...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $4,254.96 to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of Perjeta 420 mg/14 ml vials. This order is part of a larger indefinite delivery contract, SPE2DB, valued at up to $4,999,999 through 2025, which enables DLA to issue delivery orders for a broad range of pharmaceutical products to support the recurring medical supply needs of military health facilities...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $28,969.50 by the Defense Logistics Agency to provide 14 vials of Perjeta 420 mg/14 ml. The delivery order was issued against DMS Pharmaceutical Group's existing indefinite delivery contract with the Defense Logistics Agency to supply pharmaceuticals and medical supplies with a total potential value of up to $5 million through December 2025. As a woman-owned small business, DMS Pharmaceutical Group will...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $8,277 to supply Defense Logistics Agency Troop Support Medical with 14 vials of Perjeta 420 mg/14 ml. This delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency, which has a potential value of up to $5 million through December 2025 to provide various pharmaceutical items and medical supplies. As a woman-owned small business and...
- This is a delivery order awarded by the Defense Logistics Agency Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of Perjeta 420 mg/14 ml vial. The firm fixed price delivery order has a potential value of $127,121.55 and a performance period ending on October 4, 2021. DMS Pharmaceutical Group is an established pharmaceutical wholesaler that provides a range of brand and generic prescription and over-the-counter medical supplies to the U.S....
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of various pharmaceutical products. The $23,579.40 contract covers the delivery of Perjeta (pertuzumab) 420 mg/14 mL vials to support the recurring medical supply needs of military health facilities. This award is part of DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract with the DLA under the SPE2DB...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide a 420 mg/14 ml vial of the drug Perjeta. The order, valued at $112,320.24, was placed on September 20, 2021, with a completion date of October 12, 2021. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that holds various federal contracts and indefinite delivery vehicles (IDVs) to supply pharmaceuticals...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $8,277 by the Defense Logistics Agency Troop Support Medical to provide one lot of Perjeta 420 mg/14 ml vials. This order was issued against DMS Pharmaceutical Group's existing indefinite delivery contract with the Defense Logistics Agency, which has a potential value of up to $5 million through December 2025 to supply various pharmaceutical items and medical supplies. As a woman-owned small business and...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at twenty thousand six hundred ninety-two dollars and fifty cents ($20,692.50) by the Defense Logistics Agency to provide Perjeta 420 mg/14 ml vials. This delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency to supply pharmaceuticals and medical supplies with a potential value of up to five million dollars through December 2025. As a...
- The Defense Logistics Agency awarded a firm fixed price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the pharmaceutical product PERJETA 420 MG/14 ML VIAL 14ML. The $12,764.88 contract has a completion date of January 31, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds multiple federal contracts and indefinite delivery vehicles to supply a variety of pharmaceutical and medical products to the Department of...
- SPE2DB22D9316Indefinite Delivery Contract
- SPE2DB22D9316-SPE2DB24FYN03Delivery Order
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to supply the pharmaceutical product Perjeta 420 mg/14 ml vial. The order has a potential value of $8,277.00 and a completion date of January 12, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that provides a range of brand and generic prescription and over-the-counter drug supplies to the federal government, primarily the Department of Defense, through various contracts and indefinite delivery vehicles (IDVs). This specific delivery order is part of a larger DLA contract with DMS Pharmaceutical Group to provide pharmaceutical items and medical supplies to military treatment facilities worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.3k | 12/20/23 |